NantOmics, a member of the NantWorks ecosystem of companies, is a leading molecular testing company that employs an integrated panomic approach to accurately detect genomic and proteomic alterations in individual tumors, providing comprehensive molecular profiles for personalized treatment options in cancer patients.
Utilizing whole genome sequencing, RNA sequencing, and quantitative proteomics, NantOmics' proprietary analytical platform delivers actionable intelligence and molecularly driven decision support at the point of care, matching tumor-specific alterations to targeted drugs with the highest clinical relevance, ultimately enabling precision medicine for the personalized management of cancer patients.
Generated from the website